Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
NCT03026803Phase 2Terminated
- Sponsor
- City of Hope
- Start
- Nov 2006
- Primary completion
- Oct 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in hepatocellular carcinoma (HCC), sponsored by City of Hope. Started Nov 2006; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03026803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026803.